标题
Clinical Implications of Extracellular HMGA1 in Breast Cancer
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 23, Pages 5950
出版商
MDPI AG
发表日期
2019-11-26
DOI
10.3390/ijms20235950
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Treatment Combinations for Alzheimer’s Disease: Current And Future Pharmacotherapy Options
- (2019) Jeffrey L. Cummings et al. JOURNAL OF ALZHEIMERS DISEASE
- HMGA1 in cancer: Cancer classification by location
- (2019) Yuhong Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MicroRNA-4458 suppresses migration and epithelial–mesenchymal transition via targeting HMGA1 in non-small-cell lung cancer cells
- (2019) Yu Ma et al. Cancer Management and Research
- P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2
- (2019) Xiaoxiang Chen et al. Cell Death & Disease
- Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy
- (2019) Marie-Eve Beaulieu et al. Science Translational Medicine
- PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways
- (2019) Fang Wei et al. CANCER LETTERS
- Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis
- (2019) Wei Lu et al. DEVELOPMENTAL CELL
- Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer
- (2019) Ulrich Krafft et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Overexpression of HMGA1 Figures as a Potential Prognostic Factor in Endometrioid Endometrial Carcinoma (EEC)
- (2019) Antonio Palumbo Júnior et al. Genes
- MiR-503 suppresses cell proliferation and invasion of gastric cancer by targeting HMGA2 and inactivating WNT signaling pathway
- (2019) Wenjing Li et al. Cancer Cell International
- Advances in Targeted Therapies for Triple-Negative Breast Cancer
- (2019) Kelly E. McCann et al. DRUGS
- HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1
- (2019) Rossella Zanin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- let-7i inhibits proliferation and migration of bladder cancer cells by targeting HMGA1
- (2019) M-M Qin et al. BMC Urology
- A Receptor of the Immunoglobulin Superfamily Regulates Adaptive Thermogenesis
- (2019) Carmen Hurtado del Pozo et al. Cell Reports
- Extracellular Matrix Alterations in Metastatic Processes
- (2019) Paolillo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- HMGA1 Overexpression is Associated With the Malignant Status and Progression of Breast Cancer
- (2018) Cuiling Qi et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Targeting RAGE Signaling in Inflammatory Disease
- (2018) Barry I. Hudson et al. Annual Review of Medicine
- High Mobility Group A (HMGA) proteins: Molecular instigators of breast cancer onset and progression
- (2018) Riccardo Sgarra et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Lessons from the Crypt: HMGA1—Amping up Wnt for Stem Cells and Tumor Progression
- (2018) Linda Resar et al. CANCER RESEARCH
- The value of detection of S100A8 and ASAH1 in predicting the chemotherapy response for breast cancer patients
- (2018) Yu-hong Li et al. HUMAN PATHOLOGY
- Radiotherapy-induced cell death activates paracrine HMGB1-TLR2 signaling and accelerates pancreatic carcinoma metastasis
- (2018) Xuelian Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miR-26a suppresses osteosarcoma migration and invasion by directly targeting HMGA1
- (2018) Jianyong Liu et al. Oncology Letters
- HMGA2 enhances 5-fluorouracil chemoresistance in colorectal cancer via the Dvl2/Wnt pathway
- (2018) Xi Xu et al. Oncotarget
- RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer—a Review
- (2018) Gowri Palanissami et al. Hormones & Cancer
- Multiple modes of action of eribulin mesylate: Emerging data and clinical implications
- (2018) Javier Cortes et al. CANCER TREATMENT REVIEWS
- Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway
- (2018) Maoliang Huang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer
- (2018) Leisha A. Emens et al. JAMA Oncology
- Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
- (2018) S Adams et al. ANNALS OF ONCOLOGY
- Nuclear β-catenin positivity as a predictive marker of long-term survival in advanced epithelial ovarian cancer
- (2017) Bence Nagy et al. PATHOLOGY RESEARCH AND PRACTICE
- HMGA1 amplifies Wnt signalling and expands the intestinal stem cell compartment and Paneth cell niche
- (2017) Lingling Xian et al. Nature Communications
- The dual role and therapeutic potential of high-mobility group box 1 in cancer
- (2017) Si-Jia He et al. Oncotarget
- HMGA1 regulates the Plasminogen activation system in the secretome of breast cancer cells
- (2017) Giulia Resmini et al. Scientific Reports
- Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
- (2016) Annette Becker et al. CANCER CELL
- Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis
- (2016) Wei Lv et al. CANCER LETTERS
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- The High Mobility Group A1 ( HMGA1 ) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 ( MMP-2 ) in a subset of tumors
- (2016) Joelle Hillion et al. GYNECOLOGIC ONCOLOGY
- Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells
- (2016) Nadine Herwig et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)–STAT3 pathway
- (2016) Amy Belton et al. LEUKEMIA & LYMPHOMA
- Expression of miR-26a exhibits a negative correlation with HMGA1 and regulates cancer progression by targeting HMGA1 in lung adenocarcinoma cells
- (2016) Noboru Sekimoto et al. Molecular Medicine Reports
- Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis
- (2016) T Kwak et al. ONCOGENE
- MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2
- (2016) Chuannan Fan et al. Oncotarget
- HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models
- (2016) Mariacarla Andreozzi et al. NEOPLASIA
- RAGE Mediates S100A7-Induced Breast Cancer Growth and Metastasis by Modulating the Tumor Microenvironment
- (2015) M. W. Nasser et al. CANCER RESEARCH
- TGF-β1 induces HMGA1 expression in human breast cancer cells: Implications of the involvement of HMGA1 in TGF-β signaling
- (2015) XUYU ZU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- HMGA1 overexpression is associated with a particular subset of human breast carcinomas
- (2015) Romina Sepe et al. JOURNAL OF CLINICAL PATHOLOGY
- Overexpression of HMGA1 correlates with the malignant status and prognosis of breast cancer
- (2015) Ruixue Huang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase
- (2015) Thomas R. Cox et al. NATURE
- Therapy-induced tumour secretomes promote resistance and tumour progression
- (2015) Anna C. Obenauf et al. NATURE
- Challenges and opportunities for cell line secretomes in cancer proteomics
- (2015) Olga Méndez et al. Proteomics Clinical Applications
- High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma
- (2015) Yun-Fei Xu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Expression of high mobility group box 1 protein predicts a poorer prognosis for patients with osteosarcoma
- (2015) JILIANG HE et al. Oncology Letters
- HMGA1/HMGA2 protein expression and prognostic implications in gastric cancer
- (2015) Kyong-Hwa Jun et al. International Journal of Surgery
- DAMPs from Cell Death to New Life
- (2015) Emilie Vénéreau et al. Frontiers in Immunology
- HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness
- (2015) Silvia Pegoraro et al. Oncotarget
- RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis
- (2015) Mathias Dahlmann et al. Oncotarget
- Bevacizumab: A Review of Its Use in Advanced Cancer
- (2014) Gillian M. Keating DRUGS
- Enhancing the Biological Relevance of Secretome-Based Proteomics by Linking Tumor Cell Proliferation and Protein Secretion
- (2014) Josep Gregori et al. JOURNAL OF PROTEOME RESEARCH
- Clinical trial of an inhibitor of RAGE-A interactions in Alzheimer disease
- (2014) D. Galasko et al. NEUROLOGY
- The Receptor for Advanced Glycation End-Products (RAGE) Is Only Present in Mammals, and Belongs to a Family of Cell Adhesion Molecules (CAMs)
- (2014) Luca Sessa et al. PLoS One
- Cytoplasmic and/or Nuclear Expression of β-Catenin Correlate with Poor Prognosis and Unfavorable Clinicopathological Factors in Hepatocellular Carcinoma: A Meta-Analysis
- (2014) Jiang Chen et al. PLoS One
- Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein
- (2014) Le-Xing Yu et al. Nature Communications
- The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context
- (2013) Tieneke B.M. Schaaij-Visser et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial–mesenchymal transition
- (2013) Chonggao Yin et al. BREAST CANCER RESEARCH AND TREATMENT
- HMGB1 in Cancer: Good, Bad, or Both?
- (2013) R. Kang et al. CLINICAL CANCER RESEARCH
- S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma
- (2013) Jean-Baptiste Bachet et al. EUROPEAN JOURNAL OF CANCER
- Plasma HMGB-1 after the initial dose of epirubicin/docetaxel in cancer
- (2013) Tobias Arnold et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Specific siRNA Targeting Receptor for Advanced Glycation End Products (RAGE) Decreases Proliferation in Human Breast Cancer Cell Lines
- (2013) AL-Madhagi Radia et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An effect size filter improves the reproducibility in spectral counting-based comparative proteomics
- (2013) Josep Gregori et al. Journal of Proteomics
- Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer
- (2013) A. Prat et al. ONCOLOGIST
- The HMGA1-COX-2 axis: A key molecular pathway and potential target in pancreatic adenocarcinoma
- (2013) Joelle Hillion et al. PANCREATOLOGY
- HMGA1: A Master Regulator of Tumor Progression in Triple-Negative Breast Cancer Cells
- (2013) Sandeep N. Shah et al. PLoS One
- A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease
- (2012) Rashid Deane et al. JOURNAL OF CLINICAL INVESTIGATION
- Unconventional Secretion is a Major Contributor of Cancer Cell Line Secretomes
- (2012) Laura Villarreal et al. MOLECULAR & CELLULAR PROTEOMICS
- E-Cadherin/β-Catenin Complex and the Epithelial Barrier
- (2011) Xinrui Tian et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
- (2011) Adam M. Brufsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Dangers Within: DAMP Responses to Damage and Cell Death in Kidney Disease
- (2011) D. L. Rosin et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
- (2011) Javier Cortes et al. LANCET
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- High-mobility Group Box 1 is Associated with Clinicopathologic Features in Patients with Hepatocellular Carcinoma
- (2011) Wei Jiang et al. PATHOLOGY & ONCOLOGY RESEARCH
- RAGE: a single receptor fits multiple ligands
- (2011) Günter Fritz TRENDS IN BIOCHEMICAL SCIENCES
- Co-expression of nuclear and cytoplasmic HMGB1 is inversely associated with infiltration of CD45RO+ T cells and prognosis in patients with stage IIIB colon cancer
- (2010) Rui-Qing Peng et al. BMC CANCER
- The High Mobility Group A1 Gene: Transforming Inflammatory Signals into Cancer?
- (2010) L. M.S. Resar CANCER RESEARCH
- The RAGE Axis
- (2010) Shi Fang Yan et al. CIRCULATION RESEARCH
- Structural Basis for Ligand Recognition and Activation of RAGE
- (2010) Michael Koch et al. STRUCTURE
- HMGA1 Is Induced by Wnt/β-Catenin Pathway and Maintains Cell Proliferation in Gastric Cancer
- (2009) Shin-ichi Akaboshi et al. AMERICAN JOURNAL OF PATHOLOGY
- Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer
- (2009) B. K. Linderholm et al. ANNALS OF ONCOLOGY
- Pathway-Based Biomarker Search by High-Throughput Proteomics Profiling of Secretomes
- (2009) Kevin Lawlor et al. JOURNAL OF PROTEOME RESEARCH
- RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
- (2009) Louis J Sparvero et al. Journal of Translational Medicine
- Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting
- (2009) Georgina S. Butler et al. NATURE REVIEWS DRUG DISCOVERY
- Binding of S100 proteins to RAGE: An update
- (2008) Estelle Leclerc et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Diagnostic use of nuclear β-catenin expression for the assessment of endometrial stromal tumors
- (2008) Chan-Kwon Jung et al. MODERN PATHOLOGY
- Unknown
- (2008) John Klune et al. MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started